1031 related articles for article (PubMed ID: 16883934)
21. Efficacy of vitrectomy with triamcinolone assistance versus internal limiting membrane peeling for highly myopic macular hole retinal detachment.
Wei Y; Wang N; Zu Z; Bi C; Wang H; Chen F; Yang X
Retina; 2013 Jun; 33(6):1151-7. PubMed ID: 23508079
[TBL] [Abstract][Full Text] [Related]
22. Staining of vitreous with triamcinolone acetonide in retained lens surgery with phacofragmentation.
Kaynak S; Celik L; Kocak N; Oner FH; Kaynak T; Cingil G
J Cataract Refract Surg; 2006 Jan; 32(1):56-9. PubMed ID: 16516779
[TBL] [Abstract][Full Text] [Related]
23. Macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling: one-year results.
Nomoto H; Shiraga F; Yamaji H; Fukuda K; Baba T; Takasu I; Ohtsuki H
Retina; 2008 Mar; 28(3):427-32. PubMed ID: 18327134
[TBL] [Abstract][Full Text] [Related]
24. Comparison of ICG-assisted ILM peeling and triamcinolone-assisted posterior vitreous removal in diffuse diabetic macular oedema.
Bardak Y; Cekiç O; Tiğ SU
Eye (Lond); 2006 Dec; 20(12):1357-9. PubMed ID: 16294204
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes of combined sutureless vitrectomy with triamcinolone stain to manage vitreous loss resulting from posterior capsule rupture during phacoemulsification.
Chang CJ; Chiang SY; Chen CL; Wang TY
J Cataract Refract Surg; 2006 Dec; 32(12):2054-9. PubMed ID: 17137983
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal triamcinolone staining observation of residual undetached cortical vitreous after posterior vitreous detachment.
Chen TY; Yang CM; Liu KR
Eye (Lond); 2006 Apr; 20(4):423-7. PubMed ID: 15846382
[TBL] [Abstract][Full Text] [Related]
27. [Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].
Oficjalska-Młyńczak J; Jamrozy-Witkowska A; Muzyka-Woźniak M; Turno-Krecicka A; Gołebiowska B
Klin Oczna; 2006; 108(7-9):273-7. PubMed ID: 17290822
[TBL] [Abstract][Full Text] [Related]
28. Staining of the internal limiting membrane with intravitreal triamcinolone acetonide.
Tognetto D; Zenoni S; Sanguinetti G; Haritoglou C; Ravalico G
Retina; 2005 Jun; 25(4):462-7. PubMed ID: 15933593
[TBL] [Abstract][Full Text] [Related]
29. Visualization of residual perfluorocarbon liquid using intravitreal triamcinolone acetonide.
Hirata F; Tamura H; Ogura Y
Ophthalmic Surg Lasers Imaging; 2005; 36(2):169-72. PubMed ID: 15792323
[TBL] [Abstract][Full Text] [Related]
30. VITRECTOMY WITHOUT INNER LIMITING MEMBRANE PEELING FOR MACULAR RETINOSCHISIS IN HIGHLY MYOPIC EYES.
Qi Y; Duan AL; Meng X; Wang N
Retina; 2016 May; 36(5):953-6. PubMed ID: 26529553
[TBL] [Abstract][Full Text] [Related]
31. Double staining with brilliant blue G and double peeling for epiretinal membranes.
Shimada H; Nakashizuka H; Hattori T; Mori R; Mizutani Y; Yuzawa M
Ophthalmology; 2009 Jul; 116(7):1370-6. PubMed ID: 19427701
[TBL] [Abstract][Full Text] [Related]
32. Triamcinolone-assisted pars plana vitrectomy for retinal disease.
Zheng Y; Sun N; Xiong Q; Wang X; Quan Y
Yan Ke Xue Bao; 2005 Sep; 21(3):142-6. PubMed ID: 17162851
[TBL] [Abstract][Full Text] [Related]
33. Improvement of visual acuity one-year after vitreous surgery in eyes with residual triamcinolone acetonide at the macular hole.
Hikichi T; Furukawa Y; Ohtsuka H; Higuchi M; Matsushita T; Ariga H; Kosaka S; Matsushita R
Am J Ophthalmol; 2008 Feb; 145(2):267-272. PubMed ID: 18054886
[TBL] [Abstract][Full Text] [Related]
34. Lensectomy and vitrectomy with and without intravitreal triamcinolone acetonide for vascularly active stage 5 retinal detachments in retinopathy of prematurity.
Lakhanpal RR; Fortun JA; Chan-Kai B; Holz ER
Retina; 2006 Sep; 26(7):736-40. PubMed ID: 16963844
[TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy.
Paccola L; Jorge R; Barbosa JC; Costa RA; Scott IU
Acta Ophthalmol Scand; 2007 Sep; 85(6):603-8. PubMed ID: 17459031
[TBL] [Abstract][Full Text] [Related]
36. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.
Hartley KL; Smiddy WE; Flynn HW; Murray TG
Retina; 2008 Mar; 28(3):410-9. PubMed ID: 18327132
[TBL] [Abstract][Full Text] [Related]
37. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown.
Sakamoto T; Miyazaki M; Hisatomi T; Nakamura T; Ueno A; Itaya K; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):423-9. PubMed ID: 12107507
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.
Kumagai K; Furukawa M; Ogino N; Larson E; Iwaki M; Tachi N
Retina; 2009 Apr; 29(4):464-72. PubMed ID: 19289987
[TBL] [Abstract][Full Text] [Related]
39. Triamcinolone-assisted internal limiting membrane peeling.
Shah GK; Rosenblatt BJ; Blinder KJ; Grand MG; Smith M
Retina; 2005 Dec; 25(8):972-5. PubMed ID: 16340525
[TBL] [Abstract][Full Text] [Related]
40. ["Floaterectomy"--pars-plana-vitrectomy for vitreous opacities].
Weber-Varszegi V; Senn P; Becht CN; Schmid MK
Klin Monbl Augenheilkd; 2008 May; 225(5):366-9. PubMed ID: 18454374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
